Vista Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Buy
28,224
+10,458
+59% +$496K 0.35% 87
2025
Q4
$904K Sell
17,766
-3,281
-16% -$168K 0.3% 89
2025
Q3
$1.17M Buy
21,047
+5,755
+38% +$337K 0.41% 72
2025
Q2
$1.06M Sell
15,292
-769
-5% -$52.3K 0.39% 75
2025
Q1
$1.12M Buy
16,061
+7,024
+78% +$580K 0.44% 68
2024
Q4
$777K Buy
+9,037
New +$977K 0.3% 98

Other funds holding NVO

Vista Investment Management's NVO Position: Q1 2026 in Review

Vista Investment Management increased its Novo Nordisk (NVO) stake by 59% in Q1 2026, buying an estimated $496K and bringing the position to 28,224 shares worth $1.04M. The position accounts for 0.35% of the portfolio, ranked #87.

Vista Investment Management first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.17M in Q3 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Vista Investment Management held 28,224 shares of Novo Nordisk worth $1.04M as of Q1 2026.
  • Vista Investment Management bought 10,458 Novo Nordisk shares in Q1 2026, an estimated $496K.
  • Novo Nordisk made up 0.35% of Vista Investment Management's portfolio in Q1 2026, its #87 holding.
  • Vista Investment Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • Vista Investment Management's Novo Nordisk position peaked at $1.17M in Q3 2025.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Vista Investment Management's 13F filing for Q1 2026, filed 15 May 2026.